Cervical Cancer Screening Among Hispanic Women
- Conditions
- Cervical Cancer
- Interventions
- Behavioral: DVDBehavioral: Promotora
- Registration Number
- NCT01525433
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Brief Summary
In this study, 400 Hispanic women will be recruited and randomized to one of three interventions:
1. Control (no change);
2. A low-intensity information program, consisting of a video approach educating women on the importance of cervical cancer screening;
3. A higher intensity program consisting of the video plus a 'promotora' or lay-community health educator led intervention at the participant's home to encourage cervical cancer screening.
The investigators will compare which intervention is most effective in encouraging Hispanic women to undergo cervical cancer screening (Pap test)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 451
- Female
- 21 - 64 years of age
- Hispanic or Latina
- Resident of the Yakima Valley, WA, USA
- No hysterectomy
- Last PAP test (cervical screening) more than 3 years ago
- Last seen at the local clinic less than 5 years ago
- Less than 21 or greater than 64 years of age
- PAP test less 3 years ago
- Prior hysterectomy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Low Intensity Information (DVD) DVD A low-intensity information program, consisting of a video approach educating women on the importance of cervical cancer screening; High Intensity Information (Promotora) Promotora A higher intensity information program consisting of the video plus a 'promotora' or lay-community health educator led-intervention at the participant's home to encourage cervical cancer screening.
- Primary Outcome Measures
Name Time Method Participant attends cervical cancer screening Within 7 months of the intervention
- Secondary Outcome Measures
Name Time Method Patient Navigator Elapsed time from diagnosis to clinic visit Evaluation of the patient navigator program as a method to improve adherence and reduce time to follow-up among study participants who receive an abnormal Pap test result. Time to follow-up will be compared to a similar population of patients who were not part of the study who also receive a diagnosis of an abnormal Pap test.
Trial Locations
- Locations (1)
Fred Hutchinson Cancer Research Center
🇺🇸Seattle, Washington, United States